<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OIN-17010524</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-01-26</date_registration>
      <primary_sponsor>General Hospital of Chinese People's Armed Police Forces</primary_sponsor>
      <public_title>Human umbilical cord mesenchymal stem cell transplantation on diabetic peripheral neuropathy</public_title>
      <acronym />
      <scientific_title>Study of effect of human umbilical cord mesenchymal stem cell transplantation on diabetic peripheral neuropathy</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-01-05</date_enrolment>
      <type_enrolment />
      <target_size>case:40;control:12;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=17509</url>
      <study_type>Observational study</study_type>
      <study_design>Non randomized control</study_design>
      <phase>II (Phase II study)</phase>
      <hc_freetext>Diabetic Peripheral Neuropathy</hc_freetext>
      <i_freetext>case:hereditary cerebellar ataxia;control:conventional therapy;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Zheng Pei</firstname>
        <middlename />
        <lastname />
        <address>69 Yongding Road, Haidian District, Beiing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15001359498</telephone>
        <email>zhengyisheng126@126.com</email>
        <affiliation>General Hospital of Chinese people's Armed Police Forces</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>An yihua</firstname>
        <middlename />
        <lastname />
        <address>69 Yongding Road, Haidian District, Beiing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 010-57976848</telephone>
        <email>riveran@126.com</email>
        <affiliation>General Hospital of Chinese People's Armed Police Forces</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Have a clear history of diabetes;
2. sensory dysfunction, knee, Achilles tendon reflexes weaken or disappear TCSSâ‰¥6 neurophysiological abnormalities;
3. No other neuropathic drugs can be administered within six months after enrollment and during follow-up.</inclusion_criteria>
      <agemin>30</agemin>
      <agemax>70</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Nearly 3 months of application of other drugs in patients with neuropathy;
2. Severe leg ulcers or gangrene, not suitable for line lower limb intervention;
3. cancer;
4. Severe heart, liver and kidney disease;
5. Suffering from peripheral neuropathy can lead to other diseases;
6. Infection not fully controlled.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>blood sugar;HbA1C levels;Toronto clinical scoring system;electrophysiological examination;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>self-prepare</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-12-06</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>